 If there's a second arm, the control arm, that gives the best state-of-the-art therapy, and MAPS shows me that MDM in psychotherapy outperforms the state-of-the-art therapy, I would find that pretty convincing. So that's the first thing you can do. You can have a better control group. And the second is you do dose-response relationship studies.